Insurance Type Influences the Use of Drug-Eluting Stents
Objectives We sought to examine the effect of insurance type upon the likelihood of receiving a drug-eluting stent (DES). Background Recent guidelines suggest that consideration of a patient's resources should play a role in decisions to use DES. Previous studies have also documented disparitie...
Gespeichert in:
Veröffentlicht in: | JACC. Cardiovascular interventions 2010-07, Vol.3 (7), p.773-779 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objectives We sought to examine the effect of insurance type upon the likelihood of receiving a drug-eluting stent (DES). Background Recent guidelines suggest that consideration of a patient's resources should play a role in decisions to use DES. Previous studies have also documented disparities in both access to care and cardiovascular outcomes according to race, insurance, and socioeconomic status. The effect of insurance status upon the decision to use DES is unclear. Methods Patients undergoing percutaneous coronary intervention (PCI) with stenting from April 2003 to June 2009, the so-called DES era, were retrospectively analyzed. Multivariable logistic regression was performed separately for patients |
---|---|
ISSN: | 1936-8798 1876-7605 |
DOI: | 10.1016/j.jcin.2010.04.011 |